banner-medcann
medcann marks a milestone in the industry with exports of micro-propagated cannabis clones from "in vitro" plant tissue culture techniques - of the highest phytosanitary quality - to Europe

Home

A worldwide provider of cannabis genetics licensing, certified seed and derivate supply, legal and traceable to origin

Our core business focuses on the development of genetics, the production of seeds and proprietary and registered cultivars, the produvtion of certified dry flower, and the extraction and commercialitatuin of cannabis oil, within a framework of ambitious R&D programs.

Our experience and knowledge, and the leadership obtaining required permits as producer and supplier of registered cannabis genetics and derivates, places the company in a privileged position for global operations.

medcann today

Two pillars underpin medcann’s creation in 2016:

Profound understanding of the regulatory framework.

Decades of expertise in cannabis hybridization, and cultivation and transformation for medical purposes.

In 2025, medcann Pharma reafirms its strategic focus on cannabis genetics, aiming to offer the global market the highest quality, legal and formalized varieties.

medcann Pharma envisions itself as a leading supplier for both the medical cannabis and hemp industries worldwide, maintaining a broad portfolio of genetics and ensuring its continuous expansion through R&D programs and the use of state-of-the-art molecular genomics technology.

In addition, medcann Pharma extends its focus to the production and commercialization of certified dry flower, as well as the extraction of derivatives from its own genetics, further strengthening its commitment to a traceable, diverse, and market-driven product offering.

Competitive advantages

Fuentedeoro, Colombia Production and operations center

  • Total land: 23 hectares (57 acres).
  • Field sowing: 10 hectares (25 acres).
  • Reservoir with capacity 30.000 m3 approx.
  • 4 labs: seeds, tissue culture, quality & transformation.
  • Germplasm bank with 2.188 accessions.
  • Hybridization program and R&D projects.
  • Total commitment to integrated management using biocontrol agents, biological products, and natural extracts.

medcann
around the world

medcann Pharma Inc., is a Business Group with headquarters in Canada and subsidiaries in Spain, Peru and Colombia, where its Production and Operations Center is located.